IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALULA NEGA HAILE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1881424059
CMS profile
11578506
Location
COSTA MESA, CA

General Payments · PY2024

$1,445.78

  • Reported across 53 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,445.78

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,445.78 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $285.42 8
Neurocrine BioSciences, Inc. $236.14 9
Lundbeck LLC $180.87 8
ITI, Inc. $156.34 7
Alkermes, Inc. $148.89 2
E.R. Squibb & Sons, L.L.C. $103.20 3
Vanda Pharmaceuticals Inc. $64.20 3
Teva Pharmaceuticals USA, Inc. $57.49 3
Janssen Pharmaceuticals, Inc $47.93 2
Noven Therapeutics, LLC $39.33 2
ABBVIE INC. $34.29 2
Axsome Therapeutics, Inc. $32.01 1
Takeda Pharmaceuticals U.S.A., Inc. $21.92 1
Corium, Inc. $21.69 1
IDORSIA PHARMACEUTICALS US INC $16.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $1,445.78 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.22 11/22/2024 Food and Beverage Undisputed 01/23/2026 1107272732 CMS
ABBVIE INC. $20.07 12/16/2024 Food and Beverage Undisputed 01/23/2026 1107272734 CMS
Alkermes, Inc. $27.26 11/13/2024 Food and Beverage Undisputed 01/23/2026 1120510509 CMS
Alkermes, Inc. $121.63 11/14/2024 Food and Beverage Undisputed 01/23/2026 1120510511 CMS
Axsome Therapeutics, Inc. $32.01 12/03/2024 Food and Beverage Undisputed 01/23/2026 1148332129 CMS
Corium, LLC $21.69 11/01/2024 Food and Beverage Undisputed 01/23/2026 1100210474 CMS
E.R. Squibb & Sons, L.L.C. $35.76 10/25/2024 Food and Beverage Undisputed 01/23/2026 1101641656 CMS
E.R. Squibb & Sons, L.L.C. $34.20 11/18/2024 Food and Beverage Undisputed 01/23/2026 1101641634 CMS
E.R. Squibb & Sons, L.L.C. $33.24 12/05/2024 Food and Beverage Undisputed 01/23/2026 1101641645 CMS
IDORSIA PHARMACEUTICALS US INC $16.06 12/12/2024 Food and Beverage Undisputed 01/23/2026 1146758716 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.42 10/20/2024 Food and Beverage Undisputed 01/23/2026 1143476199 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.37 10/28/2024 Food and Beverage Undisputed 01/23/2026 1143476204 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.19 11/01/2024 Food and Beverage Undisputed 01/23/2026 1143476210 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.46 11/13/2024 Food and Beverage Undisputed 01/23/2026 1143476215 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.10 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143476221 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $33.92 12/04/2024 Food and Beverage Undisputed 01/23/2026 1143476226 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.88 12/12/2024 Food and Beverage Undisputed 01/23/2026 1143476232 CMS
Janssen Pharmaceuticals, Inc $21.57 10/31/2024 Food and Beverage Undisputed 01/23/2026 1077921737 CMS
Janssen Pharmaceuticals, Inc $26.36 12/05/2024 Food and Beverage Undisputed 01/23/2026 1077921595 CMS
Lundbeck LLC $9.00 10/23/2024 Food and Beverage Undisputed 01/23/2026 1146030554 CMS
Lundbeck LLC $24.06 10/23/2024 Food and Beverage Undisputed 01/23/2026 1146030556 CMS
Lundbeck LLC $19.59 10/28/2024 Food and Beverage Undisputed 01/23/2026 1146030558 CMS
Lundbeck LLC $30.27 10/31/2024 Food and Beverage Undisputed 01/23/2026 1146030560 CMS
Lundbeck LLC $25.07 11/08/2024 Food and Beverage Undisputed 01/23/2026 1146030562 CMS
Lundbeck LLC $23.43 11/20/2024 Food and Beverage Undisputed 01/23/2026 1146030564 CMS
Lundbeck LLC $24.94 12/02/2024 Food and Beverage Undisputed 01/23/2026 1146030566 CMS
Lundbeck LLC $24.51 12/19/2024 Food and Beverage Undisputed 01/23/2026 1146030568 CMS
Neurocrine Biosciences, Inc. $30.96 10/17/2024 Food and Beverage Undisputed 01/23/2026 1150937660 CMS
Neurocrine Biosciences, Inc. $31.58 10/29/2024 Food and Beverage Undisputed 01/23/2026 1150936600 CMS
Neurocrine Biosciences, Inc. $19.29 11/14/2024 Food and Beverage Undisputed 01/23/2026 1150983375 CMS
Neurocrine Biosciences, Inc. $38.47 11/15/2024 Food and Beverage Undisputed 01/23/2026 1150929303 CMS
Neurocrine Biosciences, Inc. $36.15 11/21/2024 Food and Beverage Undisputed 01/23/2026 1150931053 CMS
Neurocrine Biosciences, Inc. $35.03 12/09/2024 Food and Beverage Undisputed 01/23/2026 1150932069 CMS
Neurocrine Biosciences, Inc. $2.90 12/13/2024 Food and Beverage Undisputed 01/23/2026 1151026359 CMS
Neurocrine Biosciences, Inc. $4.16 12/14/2024 Food and Beverage Undisputed 01/23/2026 1151024711 CMS
Neurocrine Biosciences, Inc. $37.60 12/19/2024 Food and Beverage Undisputed 01/23/2026 1150929899 CMS
Noven Therapeutics, LLC $16.90 11/25/2024 Food and Beverage Undisputed 01/23/2026 1084827205 CMS
Noven Therapeutics, LLC $22.43 12/18/2024 Food and Beverage Undisputed 01/23/2026 1084827203 CMS
Otsuka America Pharmaceutical, Inc. $24.01 10/18/2024 Food and Beverage Undisputed 01/23/2026 1119086762 CMS
Otsuka America Pharmaceutical, Inc. $22.60 11/05/2024 Food and Beverage Undisputed 01/23/2026 1119086764 CMS
Otsuka America Pharmaceutical, Inc. $29.27 11/07/2024 Food and Beverage Undisputed 01/23/2026 1119086766 CMS
Otsuka America Pharmaceutical, Inc. $121.40 11/12/2024 Food and Beverage Undisputed 01/23/2026 1119086768 CMS
Otsuka America Pharmaceutical, Inc. $11.79 11/21/2024 Food and Beverage Undisputed 01/23/2026 1119086770 CMS
Otsuka America Pharmaceutical, Inc. $27.69 12/06/2024 Food and Beverage Undisputed 01/23/2026 1119086772 CMS
Otsuka America Pharmaceutical, Inc. $27.59 12/06/2024 Food and Beverage Undisputed 01/23/2026 1119086774 CMS
Otsuka America Pharmaceutical, Inc. $21.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 1119086776 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.92 10/30/2024 Food and Beverage Undisputed 01/23/2026 1137757822 CMS
Teva Pharmaceuticals USA, Inc. $19.24 11/19/2024 Food and Beverage Undisputed 01/23/2026 1151600117 CMS
Teva Pharmaceuticals USA, Inc. $13.17 12/02/2024 Food and Beverage Undisputed 01/23/2026 1151600167 CMS
Teva Pharmaceuticals USA, Inc. $25.08 12/23/2024 Food and Beverage Undisputed 01/23/2026 1151600169 CMS
Vanda Pharmaceuticals Inc. $16.03 11/04/2024 Food and Beverage Undisputed 01/23/2026 1133946100 CMS
Vanda Pharmaceuticals Inc. $21.07 12/04/2024 Food and Beverage Undisputed 01/23/2026 1133946102 CMS
Vanda Pharmaceuticals Inc. $27.10 12/18/2024 Food and Beverage Undisputed 01/23/2026 1133946104 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.